Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters










Publication year range
1.
Vet Parasitol ; 327: 110080, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38278037

ABSTRACT

Whilst healthy adult farmed red deer show little clinical indication of parasite infection, they may still be maintaining infection levels on the farm through low-level shedding of nematode eggs and lungworm larvae. This work was undertaken to establish the long-term distribution of parasite counts, to determine whether the higher counts seen in previous trials are repeatable across the same animals. All adult female red deer on a New Zealand North Island property were faecal sampled (n = 209), weighed, and body condition scored (BCS) on five sampling occasions from March - August 2021. Faecal samples were processed by modified Baermanns to recover, identify, and enumerate lungworm 1st stage larvae (FLC), and nematode faecal egg counts (FEC) were determined by mini-FLOTAC. Between animal variation for FEC was significant (p < 0.001); whilst many counts were low to zero, a few individuals were consistently shedding higher egg counts. Younger animals tended to have higher egg counts (p = 0.003), but there was no association between FEC and BCS (p = 0.22), and FEC and liveweight (p = 0.58). Modelling of the data indicated that 50% of the egg output resulted from 21% of the animals. Additionally, there was no significant association between the higher egg counts and the gastrointestinal nematode classification; 'long tails' (likely Oesophagostomum sp.) p = 0.76, and the Ostertagiinae complex p = 0.75. Lungworm counts tended to be very low (0 - 26 lpg); consistent with previous trials and literature in farmed adult deer. However, between animal differences were statistically significant (p < 0.001) indicating some animals were passing more larvae than others, and poorer conditioned animals (BCS 2.5) were significantly associated with higher larval count (p = 0.03). There was no relationship between larval count and age (p = 0.62) and larval count and liveweight (p = 0.22). Modelling indicates that 50% of pasture larval contamination was contributed by 15% of the animals. There was no correlation between nematode egg count and lungworm larvae count (p = 0.22). Adult deer may play an important role as a source of infection for young deer, therefore, an improved understanding of the distribution of infection is needed to improve parasite control.


Subject(s)
Deer , Nematode Infections , Animals , Female , Dictyocaulus , Nematode Infections/veterinary , Nematode Infections/parasitology , Larva , Farms , Parasite Egg Count/veterinary , Deer/parasitology , Feces/parasitology , Communicable Disease Control
2.
Vet Parasitol ; 325: 110079, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38029560

ABSTRACT

Resistance to the benzimidazole and macrocyclic lactone anthelmintics is widespread in Cooperia spp. on cattle farms in New Zealand. Since this was first documented in 2006 little has changed in cattle farming systems except for the widespread use of levamisole to control Cooperia spp. in young cattle (i.e., parasite control has maintained an almost total reliance on use of anthelmintics). Here we report the emergence of simultaneous resistance to the benzimidazole, macrocyclic lactone and levamisole anthelmintics in Cooperia spp. and in Ostertagia spp. Anthelmintic efficacy against nematode parasites of cattle was investigated on four commercial farms following reports of poor animal growth rates and welfare, and positive faecal egg counts, despite routine treatment with combination anthelmintics, which included levamisole. Faecal egg count reduction tests involved 15 animals per treatment group, individual egg counts (paired samples) conducted pre- and post-treatment, with eggs counted to ≤ 15 eggs per g faeces and larval cultures for morphological identification. Actives tested varied between farms but always included levamisole alone and several combination products containing levamisole. Of the 20 tests conducted (i.e., 5 products on each of 4 farms) only 3 exceeded 90% efficacy against Cooperia spp. even though 8 of the products tested were combinations containing levamisole and at least one other broad-spectrum anthelmintic. Levamisole used alone achieved efficacies between 44% and 71% against Cooperia spp. across the four trials. The only product to exceed 95% efficacy against Cooperia spp. was a combination of monepantel + abamectin which was 100% effective against all parasites. Resistance to oxfendazole in Ostertagia spp. was indicated on 3 farms, while on one farm efficacy of all the tested products was ≤75% against this parasite. All the farms involved in this study were farming intensive cattle operations with an almost total reliance on anthelmintics to control parasitism. The results clearly demonstrate the emergence of simultaneous resistance to oxfendazole, levamisole and the macrocyclic lactone anthelmintics. Despite years of advice and recommendations to change farming practices away from intensive monocultures, many farmers have continued with the practice, and some are now faced with the very real possibility of being unable to control cattle parasites on their farms.


Subject(s)
Anthelmintics , Cattle Diseases , Nematoda , Nematode Infections , Parasites , Trichostrongyloidea , Animals , Cattle , Levamisole/pharmacology , Levamisole/therapeutic use , New Zealand/epidemiology , Drug Resistance , Ovum , Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Feces/parasitology , Ostertagia , Benzimidazoles/pharmacology , Benzimidazoles/therapeutic use , Parasite Egg Count/veterinary , Cattle Diseases/drug therapy , Cattle Diseases/parasitology , Nematode Infections/drug therapy , Nematode Infections/epidemiology , Nematode Infections/veterinary
3.
Vet Parasitol ; 320: 109977, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37352579

ABSTRACT

Over the past three decades, equine strongylid egg reappearance periods (ERPs) have shortened substantially for macrocyclic lactone anthelmintics. The ERPs of ivermectin and moxidectin were originally reported in the 8-10 and 12-16 week ranges, respectively, but several recent studies have found them to be around 4-5 weeks for both actives. This loss of several weeks of suppressed strongylid egg output could have substantial implications for parasite control. This study made use of a computer simulation model to evaluate the impact of shortened ERPs on the anthelmintic performance of ivermectin and moxidectin against equine cyathostomins. The original ERPs were set to 7.1 and 15.4 weeks for ivermectin and moxidectin, respectively, while the reduced ERP was set to 4.6 weeks for both actives. Simulations were set to compare model outputs between original and reduced ERP scenarios and results expressed as percent increase in strongylid egg output, infective third stage larvae on herbage (L3h), and encysted early third stage larvae (EL3). For each drug, simulations were evaluated for two different treatment scenarios (2 and 4 treatments annually), two different age groups (yearlings and adults), and for four different climates (cold humid continental, temperate oceanic, humid subtropical, and hot/cold semi-arid). Across all simulations, there was a substantial increase of the three evaluated parameters. With the ivermectin simulations, all three parameters increased in the 100-300% range across climates, age groups and treatment intensities. The moxidectin simulations displayed a wider range of results with parameters increasing from a few hundred to several thousand percent. The increases were most pronounced for L3h in the two cooler climates, reaching as high as 6727%. Overall, the loss of anthelmintic performance was at a magnitude of 10 times larger for moxidectin compared to ivermectin. This performance loss was climate dependent, and was also affected by treatment intensity, but not by horse age. This is the first study to evaluate consequences of shortened ERPs in horses and demonstrated a substantial loss in anthelmintic performance resulting from this development. The results illustrate that anthelmintic efficacy is more than the percent reduction of fecal egg counts at 14 days post treatment, and that substantial anthelmintic performance can be lost despite FECRTs remaining at 100%.


Subject(s)
Anthelmintics , Horse Diseases , Parasites , Animals , Horses , Ivermectin/pharmacology , Ivermectin/therapeutic use , Lactones/therapeutic use , Computer Simulation , Drug Resistance , Ovum , Macrolides/pharmacology , Macrolides/therapeutic use , Anthelmintics/therapeutic use , Anthelmintics/pharmacology , Feces/parasitology , Parasite Egg Count/veterinary , Horse Diseases/drug therapy , Horse Diseases/parasitology
4.
Vet Parasitol ; 315: 109883, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36701944

ABSTRACT

The genetics of indicator traits for resistance of Angora goats to gastrointestinal nematode parasite infections, and their relationships with productivity traits, were investigated on a commercial mixed-enterprise farm in the eastern North Island of New Zealand. Faecal egg counts (FEC), specific Immunoglobulin A (IgA) and Immunoglobulin G (IgG) antibody titres against carbohydrate larval antigen (CarLA) in saliva, live weight and fleece weights were recorded from 278 goats of 19-20 months of age, run as four separate mobs (breeding bucks, castrated males (wethers), or 2 groups of breeding does). Summary statistics showed the mobs differed significantly in liveweight, loge (FEC+50), loge (IgA) and loge (IgG). Genetic parameters were estimated using an animal model with repeated records where appropriate, after adjusting for the different contemporary animal groups, using the restricted maximum likelihood (REML) package. Heritability estimates from repeated measures were 0.19 ± 0.16 for FEC, 0.28 ± 0.16 for CarLA specific IgA and 0.23 ± 0.15 for CarLA specific IgG. The CarLA specific IgA response was negatively genetically correlated with FEC (-0.99 ± 0.31) suggesting that it could be used as a selection tool for breeding resistant animals. Although the genetic and phenotypic correlations between CarLA IgA and IgG were high and significant, the analysis between loge (FEC+50) and loge CarLA IgG did not converge. Further, both FEC and CarLA IgA showed significant and favourable genetic correlations with live weight. In contrast, CarLA IgG showed an unfavourable phenotypic correlation with liveweight. While this is only a preliminary study, the results do suggest that the immunoassay measuring salivary CarLA IgA response may have utility as a selection tool for parasite resistance in some breeds of goats.


Subject(s)
Goat Diseases , Nematoda , Nematode Infections , Animals , Male , Larva , Parasite Egg Count/veterinary , Nematode Infections/parasitology , Nematode Infections/veterinary , Immunoglobulin A , Feces/parasitology , Goats , Immunoglobulin G , Carbohydrates , Goat Diseases/parasitology
5.
Vet Parasitol ; 310: 109791, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36049292

ABSTRACT

Anthelmintic resistance (AR) is an ever increasing problem for the sheep industry. Several studies worldwide have investigated reversing the trend of increasing AR and documented evidence for reversion toward susceptibility has been found. The hypothesis that resistance mutations compromise parasite fitness was drawn from this evidence. The aim of this study was to assess whether there were measurable differences in the fitness of Teladorsagia circumcincta isolates depending on their AR status. Four isolates were selected for the trial based on their known resistance status; D and M were multi-drug resistant, and T and W were susceptible to the benzimidazole, levamisole, and macrocyclic lactone anthelmintic classes. A secondary aim was to develop a series of in vitro bioassays for assessing fitness characteristics of parasites. The in vitro assays included; the cold stress test measured the number of third stage larvae (L3) developing from eggs stored at 4 °C for different lengths of time. Larval aging measured the locomotory activity of L3 after storage at 30 °C for different lengths of time. The exsheathment assay measured the exsheathment percentage of L3. Larval Length used length as a proxy for fecundity. The egg hatch assay evaluated egg hatch rate in water at room temperature. All isolates exhibited a decrease in the number of L3 recovered after storage of eggs at 4 °C (p < 0.001). Storage of L3 at 30 °C significantly influenced the ability of L3 to migrate through a 20 µm sieve (p < 0.001), however, there were no differences between isolates (p > 0.05). Exsheathment rate was higher for isolate D in comparison to isolates M and W, and for isolate T compared to isolate W. Isolate W was significantly longer than all other isolates (p < 0.05), whilst isolate M was significantly longer than isolate D (p < 0.05). No significant differences were found between isolates in egg hatch (p > 0.05). Overall, the results do not support differences in fitness associated with anthelmintic resistance status, even though differences were seen between the isolates for some assays. This suggests there is considerable variation in fitness parameters between isolates, making it difficult to determine whether resistance genotypes come with lower fitness.


Subject(s)
Anthelmintics , Sheep Diseases , Animals , Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Drug Resistance/genetics , Feces/parasitology , Ostertagia/genetics , Ovum , Parasite Egg Count/veterinary , Sheep , Sheep Diseases/drug therapy , Sheep Diseases/parasitology
6.
Vet Parasitol ; 305: 109721, 2022 May.
Article in English | MEDLINE | ID: mdl-35597692

ABSTRACT

Farmed red deer face challenges from nematode parasites, primarily the pulmonary species Dictyocaulus eckerti and the complex of Ostertagiinae nematodes in the abomasum. Previous investigations on New Zealand deer farms identified limited seasonality in faecal egg and larval output in all stock classes, however, this does not indicate the key times of year those eggs develop into infective-stage larvae, and subsequently contribute to infection risk. A simple temperature-driven model was developed for the free-living stages of a representative deer-specific Ostertagiinae species; Ostertagia leptospicularis. The model was then validated using development data generated from seasonal plot trials. Using faecal egg counts and animal numbers from the previous monitoring study, and local weather data from each of the sampling farms, the relative contribution of each stock class to infective third-stage larvae population on pasture was estimated for each month of the year (2018-2019). The mixed-age adult females were the primary source of infective larvae on most of the sampled farms, principally due to their numerical dominance (i.e., venison breeding farms). The frequent anthelmintic use in the youngest stock class (< 12 months old) on some farms limited their output of eggs and hence their contribution to pasture infestation with infective larvae. However, the trends of larval development on pasture differed between the farms (due to local climate), and between the sampling years (2018-2019). Therefore, calendar-based application of anthelmintics to older stock is not recommended, as contribution to pasture contamination is multifactorial. The study provides a better understanding of deer parasite epidemiology on which to base improved management practices.


Subject(s)
Anthelmintics , Deer , Nematoda , Nematode Infections , Animals , Anthelmintics/therapeutic use , Deer/parasitology , Farms , Feces/parasitology , Female , Larva , Nematode Infections/veterinary , New Zealand/epidemiology , Ostertagia , Ovum , Parasite Egg Count/veterinary
7.
Vet Parasitol ; 303: 109660, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35168114

ABSTRACT

Gastrointestinal nematode parasites and lungworm are significant animal health issues for farmed wapiti and red deer (Cervus elaphus). Chronic infection with gastrointestinal nematodes, coupled with sporadic, often pathogenic, outbreaks of the lungworm Dictyocaulus eckerti in young deer has resulted in many farmers relying heavily on anthelmintic treatments. An improved understanding of the epidemiology of the parasites infecting farmed deer, including the sources and seasonality of pasture contamination on the farm, is essential to the development of more integrated and sustainable control programs. The numbers of strongyle nematode eggs and lungworm larvae shed by different stock classes (red and/ or wapiti mixed-age stags, mixed-age red hinds, rising 2-year-old red stags and mix-sex rising 1-year olds) were monitored monthly, across six farms located in different regions of New Zealand, from January 2018 to early 2020. Every month, 10 fresh on-pasture faecal samples were collected from each stock class and couriered overnight to the laboratory. Baermann apparatus to recover lungworm 1st-stage larvae were set up immediately on sample arrival. Faecal samples for nematode faecal egg count were stored at 4 °C until the number of strongyle eggs were counted by mini-FLOTAC. Additional information, including stocking density, grazing systems, and anthelmintic treatments, were also noted every collection month. Results indicate a relatively consistent proportion of animals within each stock class shedding low numbers of both gastrointestinal nematode eggs (about 75 %) and lungworm larvae (about 50 %) all year round. There was little apparent seasonality and few differences between farms (location). Further, the average number of eggs/larvae shed was also relatively constant across seasons and locations, within each stock class. Interestingly, there was little correlation between lungworm larval counts and egg counts suggesting that the same animals were not consistently shedding both parasites. The data indicate that in the presence of regular anthelmintic treatments to young deer (< 1 year old), the adult stock groups constitute a potentially significant source of pasture contamination, and hence future infection. However, these data do not incorporate the seasonal effects of weather on egg/larval development, nor the number of animals of each stock class on the farms. Incorporation of these variables will be necessary to identify the sources and timing of subsequent infection. This work is currently underway.


Subject(s)
Deer , Nematoda , Nematode Infections , Animals , Deer/parasitology , Farms , Feces/parasitology , Larva , Nematode Infections/epidemiology , Nematode Infections/parasitology , Nematode Infections/veterinary , New Zealand/epidemiology , Ovum , Parasite Egg Count/veterinary , Seasons
8.
Int J Parasitol ; 51(13-14): 1133-1151, 2021 12.
Article in English | MEDLINE | ID: mdl-34774857

ABSTRACT

This review article provides an historical perspective on some of the major research advances of relevance to ruminant livestock gastrointestinal nematode control over the last 50 years. Over this period, gastrointestinal nematode control has been dominated by the use of broad-spectrum anthelmintic drugs. Whilst this has provided unprecedented levels of successful control for many years, this approach has been gradually breaking down for more than two decades and is increasingly unsustainable which is due, at least in part, to the emergence of anthelmintic drug resistance and a number of other factors discussed in this article. We first cover the remarkable success story of the discovery and development of broad-spectrum anthelmintic drugs, the changing face of anthelmintic drug discovery research and the emergence of anthelmintic resistance. This is followed by a review of some of the major advances in the increasingly important area of non-pharmaceutical gastrointestinal nematode control including immunology and vaccine development, epidemiological modelling and some of the alternative control strategies such as breeding for host resistance, refugia-based methods and biological control. The last 50 years have witnessed remarkable innovation and success in research aiming to improve ruminant livestock gastrointestinal nematode control, particularly given the relatively small size of the research community and limited funding. In spite of this, the growing global demand for livestock products, together with the need to maximise production efficiencies, reduce environmental impacts and safeguard animal welfare - as well as specific challenges such as anthelmintic drug resistance and climate change- mean that gastrointestinal nematode researchers will need to be as innovative in the next 50 years as in the last.


Subject(s)
Anthelmintics , Nematoda , Nematode Infections , Animals , Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Drug Resistance , Livestock , Nematode Infections/drug therapy , Nematode Infections/prevention & control , Nematode Infections/veterinary , Ruminants
9.
Vet Parasitol ; 298: 109538, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34364153

ABSTRACT

In the present study, an anthelmintic treatment regimen with reduced treatment frequency was evaluated in horses on two study sites in Belgium during three consecutive summer pasture seasons. Historically, the horses on both study sites were treated up to 6 times a year with ivermectin (IVM) or up to 4 times a year with moxidectin (MOX), and previous efficacy evaluations indicated a reduced egg reappearance period in some of the treated horses for both IVM (28 days) and MOX (42 days). In the present study, all horses were treated with IVM or MOX in the spring and in autumn. Faecal egg counts (FEC) were conducted every two weeks during the summer pasture season and whenever the individual FEC exceeded 250 eggs per gram of faeces, the specific horse was treated with pyrantel embonate. No increase in parasitic disease over the three-year period of the study was observed. The FEC data collected in the study as well as the age of the animals and local weather data were then imported into a cyathostomin life-cycle model, to evaluate long term effects of the newly applied treatment regimen on the selection pressure for anthelmintic resistance, and compare to the previous high frequency treatment regimen. The model simulations indicated that the whole-herd treatment regimen with at least 4 macrocyclic lactone treatments annually led 2-3 times faster resistance development than any of the alternative treatment regimens evaluated under the specific conditions of these two study sites. Further lowering the treatment frequency or applying even more selective treatments enhanced the delay in resistance development, but to a lesser extent.


Subject(s)
Horse Diseases , Ivermectin , Macrolides , Animals , Anthelmintics/administration & dosage , Anthelmintics/pharmacology , Belgium/epidemiology , Drug Resistance/drug effects , Feces/parasitology , Horse Diseases/drug therapy , Horse Diseases/epidemiology , Horse Diseases/prevention & control , Horses , Ivermectin/administration & dosage , Ivermectin/pharmacology , Macrolides/administration & dosage , Macrolides/pharmacology , Ovum/drug effects , Parasite Egg Count/veterinary
10.
Vet Parasitol ; 298: 109525, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34274762

ABSTRACT

The influence of route of administration on the pharmacokinetics and efficacy of macrocyclic lactone anthelmintics has been a subject of interest due to its potential to influence the development of anthelmintic resistance. For most parasite species studied so far, oral administration results in the highest concentrations of drug in the parasites and the highest efficacy against resistant genotypes. However, a recent study in cattle measured the highest levels of ivermectin in the abomasal Ostertagia ostertagi following subcutaneous injection, but it was not possible to correlate these elevated levels with efficacy. Therefore, the current study was initiated to determine whether injectable delivery might be optimal for attaining high efficacy against this important group of parasites. Three on-farm trials were conducted to measure the efficacy of moxidectin administered by the oral, injectable, and pour-on routes against Ostertagiinae parasites in farmed red deer. Groups of rising 1-year old stags (red or red-wapiti crossbreds) in the 84-104 kg weight range were randomised on liveweight into treatment groups of 6 (1 farm) or 8 (2 farms). Animals were treated to individual liveweight with moxidectin oral (0.2 mg/kg), injectable (0.2 mg/kg), pour-on (0.5 mg/kg) or remained untreated. Twelve days later all animals were euthanised and abomasa recovered for worm count. Adult worms were counted in a 2% aliquot of abomasal washings, and adult and fourth stage larvae in a 10 % aliquot following mucosal incubation in physiological saline. In addition, blood was collected from the same 5 animals in each of the treatment groups on days 0, 1, 2, 3, 5, 7 and 12 after treatment and moxidectin levels in plasma were determined using a mass spectrometer. The number of Ostertagiinae surviving treatment was significantly different for each of the treatment groups with injectable administration being most effective, oral administration being the next most effective and pour-on administration the least effective. This applied to both adult worms and fourth stage larvae. A similar pattern was seen in the levels of moxidectin in plasma with both the peak value and area under the concentration curve being highest following injectable administration and lowest following pour-on treatment. Although undertaken in a different host species, the results support the proposition that injectable administration of macrocyclic lactone anthelmintics is likely to be optimal for efficacy against Ostertagiinae parasites and potentially useful in slowing the emergence of resistance in these parasites.


Subject(s)
Anthelmintics , Cattle Diseases , Deer , Macrolides , Ostertagia , Animals , Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Cattle , Cattle Diseases/drug therapy , Deer/parasitology , Farms , Feces , Macrolides/pharmacology , Macrolides/therapeutic use , Ostertagia/drug effects , Parasite Egg Count/veterinary
11.
Vet Parasitol ; 292: 109401, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33770590

ABSTRACT

A group of 5 lambs (Host 1-5) was infected with the same batch of Haemonchus contortus and after patency individual faecal samples were collected, separately incubated at 23 °C for 14 days and third stage larvae collected through Baermannisation. Life-history traits were compared between larvae from different hosts: the length of the larvae was measured by microscope image analysis, larval survival in water at 35 °C, larval susceptibility to ivermectin (EC50) in a migration assay, the proportion of larvae exsheathing in vitro and the proportion establishing to the adult stage in young lambs. For all traits there were significant differences between the host animals, with larvae from specific hosts following a consistent pattern of displaying the highest or lowest trait results. Compared with larvae from Host 1 the larvae from Host 5 were () shorter (741-692 µm, p < 0.05), had a longer median survival at 35 °C (3.6-6.4 days, p < 0.05), were less susceptible to ivermectin (EC50 of 1.2 v 4.5 µM, p < 0.05), exsheathed to a lesser degree (83.6-58 %, p < 0.05), but showed a higher establishment rate in the consecutive host (15.2-31.4 %, p < 0.05). Regarding the survival time, anthelmintic susceptibility (under most commercial farming practices) and establishment rate as indicators for fitness, the parasites populating Host 5 produced progeny of higher fitness. The findings indicate that the host animal of the parental parasite generation has a significant effect on the parasite progeny.


Subject(s)
Haemonchiasis/veterinary , Haemonchus/physiology , Sheep Diseases/parasitology , Animals , Antiparasitic Agents/therapeutic use , Haemonchiasis/parasitology , Host-Parasite Interactions , Ivermectin/therapeutic use , Male , Sheep
12.
Sci Rep ; 11(1): 3836, 2021 02 15.
Article in English | MEDLINE | ID: mdl-33589656

ABSTRACT

Anthelmintic treatment of adult ewes is widely practiced to remove parasite burdens in the expectation of increased ruminant productivity. However, the broad activity spectra of many anthelmintic compounds raises the possibility of impacts on the rumen microbiota. To investigate this, 300 grazing ewes were allocated to treatment groups that included a 100-day controlled release capsule (CRC) containing albendazole and abamectin, a long-acting moxidectin injection (LAI), and a non-treated control group (CON). Rumen bacterial, archaeal and protozoal communities at day 0 were analysed to identify 36 sheep per treatment with similar starting compositions. Microbiota profiles, including those for the rumen fungi, were then generated for the selected sheep at days 0, 35 and 77. The CRC treatment significantly impacted the archaeal community, and was associated with increased relative abundances of Methanobrevibacter ruminantium, Methanosphaera sp. ISO3-F5, and Methanomassiliicoccaceae Group 12 sp. ISO4-H5 compared to the control group. In contrast, the LAI treatment increased the relative abundances of members of the Veillonellaceae and resulted in minor changes to the bacterial and fungal communities by day 77. Overall, the anthelmintic treatments resulted in few, but highly significant, changes to the rumen microbiota composition.


Subject(s)
Anthelmintics/pharmacology , Microbiota/drug effects , Rumen/microbiology , Animals , Anthelmintics/administration & dosage , Biodiversity , Duration of Therapy , Dysbiosis/etiology , Sheep , Sheep Diseases/drug therapy , Sheep Diseases/parasitology
13.
Equine Vet J ; 53(5): 902-910, 2021 Sep.
Article in English | MEDLINE | ID: mdl-33119179

ABSTRACT

BACKGROUND: Strongylid and ascarid parasites are omnipresent in equine stud farms, and ever-increasing levels of anthelmintic resistance are challenging the industry with finding more sustainable and yet effective parasite control programs. OBJECTIVES: To evaluate egg count levels, bodyweight and equine health under defined parasite control protocols in foals and mares at two Standardbred and two Thoroughbred stud farms. STUDY DESIGN: Longitudinal randomised field trial. METHODS: A total of 93 foals were enrolled and split into two treatment groups, and 99 mares were enrolled and assigned to three treatment groups. All horses underwent a health examination, and episodes of colic or diarrhoea were recorded at each faecal collection date. Bodyweights were assessed using a weight tape, and mares were body condition scored. Group A foals (FA) were dewormed at 2 and 5 months of age with a fenbendazole/ivermectin/praziquantel product, while group B foals (FB) were dewormed on a monthly basis, alternating between the above-mentioned product and an oxfendazole/pyrantel embonate product. Group A mares (MA) were dewormed twice with fenbendazole/ivermectin/praziquantel, group B mares (MB) were dewormed with the same product, when egg counts exceeded 300 strongylid eggs per gram, and group C mares (MC) were dewormed every 2 months, alternating between the two products. Health data were collected monthly for 6 months (foals) and bimonthly for 13 months (mares). Data were analysed with mixed linear models and interpreted at the α = 0.05 significance level. RESULTS: There were no significant bodyweight differences between foal groups, but MA mares were significantly lighter than the other two groups. Very few health incidents were recorded. Foals in group FA had significantly higher ascarid and strongylid egg counts, whereas no significant differences were observed between mare groups. MAIN LIMITATIONS: Study duration limited to one season. CONCLUSIONS: Anthelmintic treatment intensity was lowered from the traditional intensive regimes without measurable negative health consequences for mares and foals.


Subject(s)
Anthelmintics , Ascaridida Infections , Ascaridoidea , Horse Diseases , Parasites , Animals , Anthelmintics/therapeutic use , Ascaridida Infections/veterinary , Feces , Female , Fenbendazole/therapeutic use , Horse Diseases/drug therapy , Horses , Parasite Egg Count/veterinary
14.
Article in English | MEDLINE | ID: mdl-32992276

ABSTRACT

Climate change is likely to influence livestock production by increasing the prevalence of diseases, including parasites. The traditional practice of controlling nematodes in livestock by the application of anthelmintics is, however, increasingly compromised by the development of resistance to these drugs in parasite populations. This study used a previously developed simulation model of the entire equine cyathostomin lifecycle to investigate the effect a changing climate would have on the development of anthelmintic resistance. Climate data from six General Circulation Models based on four different Representative Concentration Pathways was available for three New Zealand locations. These projections were used to estimate the time resistance will take to develop in the middle (2040-49) and by the end (2090-99) of the century in relation to current (2006-15) conditions under two treatment scenarios of either two or six yearly whole-herd anthelmintic treatments. To facilitate comparison, a scenario without any treatments was included as a baseline. In addition, the size of the infective and parasitic stage nematode population during the third simulation year were estimated. The development of resistance varied between locations, time periods and anthelmintic treatment strategies. In general, the simulations indicated a more rapid development of resistance under future climates coinciding with an increase in the numbers of infective larvae on pasture and encysted parasitic stages. This was especially obvious when climate changes resulted in a longer period suitable for development of free-living parasite stages. A longer period suitable for larval development resulted in an increase in the average size of the parasite population with a larger contribution from eggs passed by resistant worms surviving the anthelmintic treatments. It is projected that climate change will decrease the ability to control livestock parasites by means of anthelmintic treatments and non-drug related strategies will become increasingly important for sustainable parasite control.


Subject(s)
Anthelmintics , Drug Resistance , Horse Diseases , Animals , Anthelmintics/pharmacology , Climate Change , Horse Diseases/drug therapy , Horse Diseases/parasitology , Horses , New Zealand
15.
Int J Parasitol Drugs Drug Resist ; 10: 118-124, 2019 08.
Article in English | MEDLINE | ID: mdl-31491731

ABSTRACT

Selective anthelmintic therapy has been recommended as a sustainable strategy for cyathostomin control in horse populations for several decades. The traditional approach has been to determine strongyle fecal egg counts (FEC) for all horses, with treatment only recommended for those exceeding a predetermined threshold. The aims are to achieve a reduction of overall egg shedding, while leaving a proportion of the herd untreated, which lowers anthelmintic treatment intensity and reduces selection pressure for development of anthelmintic resistance. This study made use of the cyathostomin model to evaluate the influence of treatment strategies with between 1 and 8 yearly treatment occasions, where either 1) all horses were treated, 2) a predetermined proportion of the herd remained untreated, or 3) horses were treated if their FEC exceeded thresholds between 100 and 600 strongyle eggs per gram. Weather data representing four different climatic zones was used and three different herd age structures were compared; 1) all yearlings, 2) all mature horses 10-20 years old, and 3) a mixed age structure of 1-20 years of age. Results indicated a consistent effect of age structure, with anthelmintic resistance developing quickest in the yearling group and slowest among the mature horses. Development of anthelmintic resistance was affected by treatment intensity and selective therapy generally delayed resistance. Importantly, the results suggest that the effects of selective therapy on resistance development are likely to vary between climatic zones and herd age structures. Overall, a substantial delaying of resistance development requires that the average number of treatments administered annually across a herd of horses needs to be about two or less. However, results also indicate that an age-structured prioritisation of treatment to younger horses should still be effective. It appears that a 'one-size-fits-all' approach to the management of anthelmintic resistance in cyathostomins is unlikely to be optimal.


Subject(s)
Anthelmintics/administration & dosage , Drug Resistance , Strongyle Infections, Equine/drug therapy , Strongylida/drug effects , Age Factors , Animals , Feces/parasitology , Female , Horses , Male , Parasite Egg Count , Refugium , Strongyle Infections, Equine/parasitology , Strongylida/physiology
16.
Vet Parasitol ; 269: 28-33, 2019 May.
Article in English | MEDLINE | ID: mdl-31079825

ABSTRACT

Previously described models for the free-living and parasitic phases of the cyathostomin life-cycle were combined into a single model for the complete life-cycle. The model simulates a single free-living population on pasture utilising parasite egg output from the horses and localised temperature and rainfall data to estimate infective larval density on herbage. Multiple horses of different ages are possible, each with an individualised anthelmintic treatment programme. Genotypes for anthelmintic resistance are included allowing for up to three resistance genes with 2 alleles each. Because little is known of the genetics of resistance to anthelmintics in cyathostomins, the first use of this model was to compare the effect of different assumptions regarding the inheritance of resistance on model outputs. Comparisons were made between single and two-gene inheritance, where the heterozygote survival was dominant, intermediate or recessive under treatment, and with or without a fitness disadvantage associated with the resistance mechanism. Resistance developed fastest when the heterozygotes survived anthelmintic treatment (i.e., were dominant) and slowest when they did not (i.e., were recessive). Resistance was slower to develop when inheritance was poly-genic compared to a single gene, and when there was a fitness cost associated with the resistance mechanism, although the latter variable was the least influential. Importantly, while these genetic factors sometimes had a large influence on the rate at which resistant genotypes built up in the model populations, their order of ranking was always the same, when different anthelmintic use strategies were compared. Therefore, the described model is a useful tool for evaluating different treatment and management strategies on their potential to select for resistance.


Subject(s)
Anthelmintics/pharmacology , Computer Simulation , Drug Resistance/genetics , Horse Diseases/parasitology , Strongyle Infections, Equine/parasitology , Strongyloidea/genetics , Animals , Female , Horse Diseases/drug therapy , Horses , Larva , Parasite Egg Count/veterinary , Strongyle Infections, Equine/drug therapy , Strongyloidea/drug effects , Strongyloidea/physiology
17.
Vet Parasitol ; 269: 7-12, 2019 May.
Article in English | MEDLINE | ID: mdl-31079830

ABSTRACT

Anthelmintic resistance is widespread in equine cyathostomin populations across the world, and with no new anthelmintic drug classes in the pharmaceutical pipeline, the equine industry is forced to abandon traditional parasite control regimens. Current recommendations aim at reducing treatment intensity and identifying high strongylid egg shedders in a targeted treatment approach. But, virtually nothing is known about the effectiveness of these recommendations, nor their applicability to different climatic regions, making it challenging to tailor sustainable recommendations for equine parasite control. This study made use of a computer model of the entire cyathostomin life-cycle to evaluate the influence of climate and seasonality on the development of anthelmintic resistance in cyathostomin parasites. Furthermore, the study evaluated the impact of recommended programs involving selective anthelmintic therapy on delaying anthelmintic resistance development. All simulations evaluated the use of a single anthelmintic (i.e., ivermectin) over the course of 40 model years. The study made use of weather station data representing four different climatic zones: a cold humid continental climate, a temperate oceanic climate, a cold semi-arid climate, and a humid subtropical climate. Initially, the impact of time of the year was evaluated when a single anthelmintic treatment was administered once a year in any of the twelve months. The next simulations evaluated the impact of treatment intensities varying between 2 and 6 treatments per year. And finally, we evaluated treatment schedules consisting of a combination of strategic treatments administered to all horses and additional treatments administered to horses exceeding a predetermined fecal egg count threshold. Month of treatment had a large effect on resistance development in colder climates, but little or no impact in subtropical and tropical climates. Resistance development was affected by treatment intensity, but was also strongly affected by climate. Selective therapy delayed resistance development in all modelled scenarios, but, again, this effect was climate dependent with the largest delays observed in the colder climates. This study is the first to demonstrate the value of cyathostomin parasite refugia in managing anthelmintic resistance, and also that climate and seasonality are important. This modelling exercise has allowed an illustration of concepts believed to play important roles in anthelmintic resistance in equine cyathostomins, but has also identified knowledge gaps and new questions to address in future studies.


Subject(s)
Anthelmintics/pharmacology , Computer Simulation , Drug Resistance , Horse Diseases/parasitology , Strongyle Infections, Equine/parasitology , Strongyloidea/drug effects , Animals , Climate , Horse Diseases/drug therapy , Horses , Ivermectin/pharmacology , Refugium , Seasons , Strongyle Infections, Equine/drug therapy , Weather
18.
Vet Parasitol ; 268: 53-60, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30981306

ABSTRACT

A model was developed to reproduce the dynamics of the parasitic stages of equine cyathostomins. Based on a detailed review of published literature, a deterministic simulation model was constructed using the escalator boxcar-train approach, which allows for fully-overlapping cohorts of worms and approximately normally distributed variations in age/size classes. Key biological features include a declining establishment of ingested infective stage larvae as horses age. Development rates are constant for all the parasitic stages except the encysted early third stage larvae, for which development rates are variable to reflect the sometimes extended arrestment of this stage. For these, development is slowed in the presence of adult worms in the intestinal lumen, and when ingestion of infective larvae on herbage is high or extended. In the absence of anthelmintic treatments, the life span of adult worms is approximately 12 months, and the presence of an established adult worm burden largely blocks the transition of luminal fourth stage larvae to the adult stage, resulting in mortality of the larvae. This inhibition is removed by effective anthelmintic treatment allowing the rapid replacement of adult worms from the pool of mucosal stages. Within the model, the rate and seasonality at which infective stage larvae are ingested strongly influences the dynamics of the pre-adult stages. While the adult worm burden remains relatively stable within a year, due to the negative feedback they have on developing stages, the numbers and proportions of larval stages relative to the total worm burden increase with the numbers of infective larvae ingested. Further, within the model, the seasonal rise and fall of encysted stages is largely driven by the seasonal pattern of infective larvae on pasture. Because of this, the model reproduces the contrasting seasonal patterns of mucosal larvae, typical of temperate and tropical environments, using only the appropriate seasonality of larvae on pasture. Thus, the model reproduces output typical of different climatic regions and suggests that observed patterns of arrested development may simply reflect the numbers and seasonality of free-living stages on pasture as determined by different management practices and weather patterns.


Subject(s)
Horse Diseases/parasitology , Horses/microbiology , Life Cycle Stages , Models, Theoretical , Strongyloidea/growth & development , Animals , Anthelmintics/therapeutic use , Feces/parasitology , Female , Larva/drug effects , Larva/growth & development , Seasons , Strongyle Infections, Equine/drug therapy , Strongyloidea/drug effects , Weather
19.
Parasitol Res ; 118(2): 707-710, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30607609

ABSTRACT

A crucial step in the infection process of grazing ruminants by gastro-intestinal nematodes is the exsheathment of the infective third-stage larva following ingestion. Recently, heat shock was shown to play an important role in the carbon dioxide (CO2)-dependent exsheathment response in Haemonchus contortus. The current in vitro study set out to evaluate the role of heat shock in other abomasal species. In rumen fluid, all species tested exsheathed rapidly and efficiently in response to heat shock and CO2. This response was significantly higher compared to slow temperature changes, supporting the hypothesis that heat shock plays an important role in vivo. However, in artificial buffer, the effect of heat shock was species-dependent. For H. contortus and Ostertagia leptospicularis, the response in artificial buffer was similar to rumen fluid. In contrast, Ostertagia ostertagi and Teladorsagia circumcincta exsheathment was significantly lower and/or slower in artificial buffer, and there was no benefit of heat shock. For these two species, it appears that there are co-factors in the rumen fluid, in addition to heat shock and CO2, contributing to exsheathment. Overall, the data indicate that there are significant differences between abomasal species in their response to exsheathment triggers.


Subject(s)
Abomasum/parasitology , Carbon Dioxide/pharmacology , Haemonchus/physiology , Heat-Shock Response/physiology , Ostertagia/physiology , Trichostrongyloidea/physiology , Animals , Gastrointestinal Tract/parasitology , Larva/physiology , Rumen/parasitology , Ruminants/parasitology
20.
Vet Parasitol ; 264: 64-68, 2018 Dec 15.
Article in English | MEDLINE | ID: mdl-30503094

ABSTRACT

The establishment rate of Cooperia oncophora related to host age and previous infection was investigated in young calves. Calves of similar age were kept on a feed pad and allocated into multiple groups, based on their age and weight. Two groups (each n = 16) received trickle infections with an ivermectin-susceptible C. oncophora isolate of 2000 or 10,000 infective stage larvae per week while another group (n = 16) was kept as an uninfected control. At intervals over a period of 11 months, two animals from each group were challenged with 15,000 infective stage larvae of an ivermectin-resistant isolate, 25 days later orally treated with ivermectin and 5 days after that slaughtered for worm counts. On three occasions additional calves (n = 2), subjected to the high trickle infection rate, received an ivermectin treatment to remove the existing worm burden, prior to challenge as above. Further calves (n = 4) of similar age were introduced at the beginning and the end of the experiment to determine the effect of larval age on establishment rate. The establishment in the two trickle infection groups declined to <10% within the first three months, which was significantly different from the control group. In the animals receiving the high trickle infection, but an anthelmintic treatment before challenge the establishment rate was not significantly different from the controls. Over the duration of the experiment establishment in the control group declined from 53% to <20%, which was similar to the decrease recorded at the beginning and the end of the experiment in the animals to determine the effect of larval age. The findings indicate that an existing C. oncophora burden had a strong effect on the establishment of incoming larvae in the trickle infected groups, but this was not observed if the existing burden was removed before the final challenge. The decline in establishment rate in the control group was attributed to the age of the larvae and not the age of the calves per se.


Subject(s)
Cattle Diseases/parasitology , Trichostrongyloidiasis/immunology , Trichostrongyloidiasis/parasitology , Animals , Cattle , Cattle Diseases/drug therapy , Disease Susceptibility/immunology , Disease Susceptibility/parasitology , Ivermectin/therapeutic use , Parasite Egg Count , Trichostrongyloidea/immunology , Trichostrongyloidiasis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...